Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma

Principal Investigator: Fountzilas, Christos

A FIRST-IN-HUMAN PHASE 1/2 OPEN-LABEL STUDY OF INTRAVENOUS ST 067, SUBCUTANEOUS ST-067 WITH OR WITHOUT OBINUTUZUMAB PRE TREATMENT, AND ST-067 IN COMBINATION WITH PEMBROLIZUMAB IN SUBJECTS WITH ADVANCED SOLID MALIGNANCIES

Principal Investigator: Puzanov, Igor

Financial Compass: A Pilot Feasibility Study of a Novel Intervention to Identify and Address Financial Hardship among Cancer Patients

Principal Investigator: Bouchard, Elizabeth G

IDE196 (DAROVASERTIB) IN COMBINATION WITH CRIZOTINIB VERSUS INVESTIGATOR'S CHOICE OF TREATMENT AS FIRST-LINE THERAPY IN HLA-A2 NEGATIVE METASTATIC UVEAL MELANOMA (DAR-UM-2)

Principal Investigator: Switzer, Benjamin J

Multi-Cohort, Open-Label, Phase 1/2 Study of DCC-3084 as Monotherapy and in Combination with Other Antitumor Agents in Participants with Advanced Malignancies Driven by the MAPK Pathway

Principal Investigator: Jain, Prantesh

I Can Join the Fight Against Cancer: An intervention to programmatically build grassroots actions to reduce the cancer burden.

Principal Investigator: Bouchard, Elizabeth G

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Principal Investigator: Bouchard, Elizabeth G

MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication Adherence

Principal Investigator: Kelly, Kara M

Addressing Disparities in Breast Cancer Care: An approach to health equity

Principal Investigator: Glaser, Kathryn M

A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

Principal Investigator: Zsiros, Emese

Asciminib as Initial Therapy with Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia who do not Achieve Optimal Response or a Deep Molecular Remission (ALERT CML)

Principal Investigator: Thompson, J

A Comprehensive Education and Navigational Support Program for Advanced Bladder Cancer

Principal Investigator: George, Saby

Symptom Management in the Hematopoietic Stem Cell Transplantation Patient Population Using Virtual Reality

Principal Investigator: Huizinga, Heather E

A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor…

Principal Investigator: Fountzilas, Christos

A032102: PRECISION DIAGNOSTICS IN PROSTATE CANCER TREATMENT (PREDICT)

Principal Investigator: Chatta, Gurkamal S

A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction

Principal Investigator: Ivanick, Nathaniel M

Respiratory Muscle Training During Breast Cancer Treatment: Effects on the Autonomic Nervous System and Cardiotoxicity

Principal Investigator: Levine, Ellis G

A Phase IIa Study of Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab in Patients with Asymptomatic Brain Metastasis from Triple Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC) or Hormone Receptor Positive (HR+) Breast Cancer.

Principal Investigator: Kabraji, Sheheryar K

A PHASE 1/2 STUDY OF LINVOSELTAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC LIGHT CHAIN AMYLOIDOSIS

Principal Investigator: Hassan, Hamza

An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer

Principal Investigator: Dy, Grace K

Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients with Loco-regionally Advanced or Recurrent Colorectal Cancer Undergoing Surgery; Phase I/II

Principal Investigator: Dakwar, Anthony

Phase 1/2, Open-Label, Multi-Center, Dose Escalation and Expansion Study Evaluating the Safety, Tolerability and Clinical Activity of Decoy20 as Monotherapy and in Combination with Tislelizumab in Patients with Advanced Solid Tumors

Principal Investigator: Krishnamurthy, Anuradha

Thriving Beyond Breast Cancer: Post-Treatment Supportive Services Programming for Black Women to Alleviate Disparities During Survivorship

Principal Investigator: Devonish, Julia A

A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Principal Investigator: Holtan, Shernan G

Sensory Evaluation of Cigarettes Claiming Removal of Menthol as a Characterizing Flavor

Principal Investigator: O'Connor, Richard J